Post-Marketing Surveillance Study of Hepatitis A Vaccine in Korean Population
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose : This post-marketing surveillance (PMS) study was conducted in Korea to assess the safety and reactogenicity of hepatitis A vaccine (GlaxoSmithKlineBiologicals'HavrixTM) administered to the Korean population. Methods : A total of 1,188 healthy subjects with 1,122 subjects <6 years of age were enrolled to receive one dose of the hepatitis A vaccine from April 2005 to January 2006. Diary cards were provided to the subjects or subjects' parents for reporting solicited and unsolicited symptoms during the 4-day and 31-day post-vaccination follow-up period. Results : The number of subjects who returned diary cards was 568, whereas, 620 subjects did not return diary cards. Among the subjects who returned diary cards, 9.9% and 14.3% reported local and general solicited/unsolicited symptoms. Among the subjects who did not return diary cards, 1.6% and 8.4% reported local and general solicited/unsolicited symptoms. At least one unsolicited symptom was reported by 13.2% of the subjects. Conclusion : Results indicate that the vaccine was well-tolerated and had an acceptable safety profile. The use of diary cards in such a survey provided a prompt and reliable option for recording symptoms. (Korean J Pediatr Infect Dis 2008;15:115-120)
Abstract
Purpose : This post-marketing surveillance (PMS) study was conducted in Korea to assess the safety and reactogenicity of hepatitis A vaccine (GlaxoSmithKlineBiologicals'HavrixTM) administered to the Korean population. Methods : A total of 1,188 healthy subjects with 1,122 subjects <6 years of age were enrolled to receive one dose of the hepatitis A vaccine from April 2005 to January 2006. Diary cards were provided to the subjects or subjects' parents for reporting solicited and unsolicited symptoms during the 4-day and 31-day post-vaccination follow-up period. Results : The number of subjects who returned diary cards was 568, whereas, 620 subjects did not return diary cards. Among the subjects who returned diary cards, 9.9% and 14.3% reported local and general solicited/unsolicited symptoms. Among the subjects who did not return diary cards, 1.6% and 8.4% reported local and general solicited/unsolicited symptoms. At least one unsolicited symptom was reported by 13.2% of the subjects. Conclusion : Results indicate that the vaccine was well-tolerated and had an acceptable safety profile. The use of diary cards in such a survey provided a prompt and reliable option for recording symptoms. (Korean J Pediatr Infect Dis 2008;15:115-120)
참고문헌 (22)
- "World Health Organization (Department of communicable disease surveillance and response", pp.1~39 (2000), Hepatitis A
- World Health Organization. Hepatitis A vaccines WHO position paper, , Wkly Epidemiol Rec, 75, pp.38~44 (2000)
- Andre FE, "Universal mass vaccination against hepatitis A", Curr Top Microbiol Immunol, 304, pp.95~114 (2006)
- Kane MA, "Perspectives on the control of hepatitis A by vaccination", Vaccine, 10, pp.S93~S96 (1992)
- Van Damme P, "Effect of hepatitis A vaccination programs", JAMA, 294, pp.246~248 (2005)
- Van Herck K, "Prevention of hepatitis A by Havrix: a review", Expert Rev Vaccines, 4, pp.459~471 (2005)
- Sohn YM, "The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea", Yonsei Med J, 41, pp.34~39 (2000)
- Kang JH, "Changing hepatitis A epidemiology and the need for vaccination in Korea", Asian Pac J Allergy Immunol, 22, pp.237~242 (2004)
- Lee SD, "Asian perspective on viral hepatitis A", J Gastroenterol Hepatol, 15, pp.G94~G99 (2000)
- Lee SD, "Immunogenicity of inactivated hepatitis A vaccine in children", Gasteroenterolgy, 04, pp.1129~1132 (1993)
- Tozzi AE, "Field evaluation of vaccine safety", Vaccine, 22, pp.2091~2095 (2004)
- "The Korean Pediatrics Society", pp.81~5 (2006), Immunization Q&A
- Andre F, "Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use", Expert Rev Vaccines, 1, pp.9~23 (2002)
- Horng YC, "Safety and immunogenicity of hepatitis A vaccine in healthy children", Pediatr Infect Dis J, 12, pp.359~362 (1993)
- Bienzle U, "Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other travellers vaccines with the immune response", Vaccine, 14, pp.501~505 (1996)
- Center for disease control, "Prevention of hepatitis A through active and passive immunization", MMWR, 55, pp.1~23 (2006)
- Clemens R, "Clinical experience with inactivated hepatitis A vaccine (Article in German)", Padiatrie und Grenzgebiete, 35, pp.237~248 (1996)
- Innis BL, "Protection against hepatitis A by an inactivated vaccine", JAMA, 271, pp.1328~1334 (1994)
- Clemens R, "Clinical experience with an inactivated hepatitis A vaccine", J Infect Dis, 171, pp.S44~S49 (1995)